share_log

Navidea Biopharmaceuticals | 8-K: Navidea Biopharmaceuticals Reports Third Quarter 2022 Financial Results

SEC ·  Nov 15, 2022 15:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more